Share Facts About the New Viral Vector COVID-19 Vaccines

March 2021

You'll hear buzz about "viral vector" COVID-19 vaccines.

Health Canada approved an interim order for the AstraZeneca (ChAdOx1-S) COVID-19 vaccine...and is currently reviewing the Johnson & Johnson/Janssen (Ad26.COV2.S) product.

These viral vector vaccines give our cells instructions to make the SARS-CoV-2 spike protein to trigger an immune response...similar to the mRNA COVID-19 vaccines from Pfizer-BioNTech or Moderna.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

COVID-19 Share Facts About the New Viral Vector COVID-19 Vaccines
Immunizations Reduce Risk of Injury and Manage Pain From IM Vaccinations
Asthma Weigh Pros and Cons of SMART for Moderate to Severe Asthma
Substance Use Disorder Compare New Buprenorphine Forms for Opioid Use Disorder
IBS Sort Out Meds for Irritable Bowel Syndrome
Opioids Stay Vigilant When Dispensing Fentanyl Rxs
Prediabetes Focus on Lifestyle Changes to Help Tackle Prediabetes
Headache Advise Starting Treatment ASAP for Cluster Headaches
OTC Products Answer Burning Questions About Cystoplus for Bladder Symptoms

Share Facts About the New Viral Vector COVID-19 Vaccines

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents